Back to School: How biopharma can reboot drug development. Access exclusive analysis here

More NBIX Indiplon-MR Phase III insomnia data

Neurocrine (NBIX) said in a double-blind, placebo-controlled U.S. Phase III trial in 229 elderly

Read the full 144 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE